| 标题 |
Abstract 452: ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:Anneleen Daemen; Alexandr Pankov; Natalie Yuen; Amber Wang; Livia Ulicna; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)